An independent peer-reviewed study found that Lifeward's ReWalk Personal Exoskeleton can be safely used at home for a median of 33 months by individuals with chronic paraplegia, with no falls or fractures reported. Users maintained over 3,000 steps per month and reported improved quality of life, mental health, and reduced pain. The study supports broader adoption and reimbursement of ReWalk, highlighting its potential to enable long-term mobility and independence beyond initial rehabilitation.
Lifeward's ReWalk Personal Exoskeleton shows promising long-term home use and patient satisfaction. For readers following health-sector stocks, here is Pluang's market snapshot as of Oct 14, 2026 19:01 WIB: out of 150 US health stocks, 105 rose and 40 fell. Guardant Health Inc. (GH) traded at USD 158.20 with 0% sell and 100% buy orders, DENTSPLY SIRONA Inc (XRAY) rose 2.18% to USD 8.69, and Alcon AG (ALC) rose 1.86% to USD 64.17 with 100% buy orders.
BlackRock reported a strong third quarter with adjusted earnings of $15.93 per share, beating estimates by a wide margin and marking a 38% increase year-over-year. Revenue grew 19% to $7.75 billion, driven by $205 billion in net client inflows, inclu...
Home BancShares will release its Q3 2026 earnings report on October 14, with analysts expecting earnings per share of $0.64 and revenue around $293-$294 million, marking a 5.5% revenue increase and 4.9% EPS growth from last year. The bank's P/E ratio...
Hyperion Materials & Technologies has acquired The Ultra-Met Company, a tungsten carbide manufacturer based in Urbana, Ohio, to expand its capabilities in serving the US aerospace and defense sectors. Ultra-Met works closely with the US Department of...
Morgan Stanley reported Q3 earnings per share of $3.03, surpassing analyst estimates of $2.93 and $2.83 consensus. Revenue reached $20.34 billion, a 12% increase year-over-year and above the $19.93 billion estimate. Strong equity trading and record w...
Bank of New York Mellon is set to report its Q3 2026 earnings, with analysts expecting earnings per share of $2.27 and revenue of $5.55 billion. This represents an 18.3% increase in earnings and a 9.5% rise in revenue compared to the previous year, d...
